Gut Bacteria Changes Predict Cognitive Decline Before Symptoms Appear
Multiomics study reveals gut microbiome shifts and inflammation markers detectable in earliest stages of cognitive decline.
Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
370 articoli
Multiomics study reveals gut microbiome shifts and inflammation markers detectable in earliest stages of cognitive decline.
New cerebrospinal fluid protein biomarker can predict which Alzheimer's patients will maintain cognitive function despite brain pathology.
New research reveals how declining estrogen and gut bacteria changes create a perfect storm for Alzheimer's disease in women.
New study shows eating fiber-rich, microbiota-supporting foods improves cognitive function through gut bacteria mediation.
New review reveals how gut microbes trigger Alzheimer's, Parkinson's, and other brain diseases via inflammation and toxic metabolites.
New review reveals how antioxidants modify gut microbiota to reduce brain inflammation and slow neurodegenerative disease progression.
Single-cell analysis reveals how the flavonoid fisetin may reduce neuroinflammation in Alzheimer's disease by targeting specific astrocyte subgroups.
Researchers develop 98% accurate plasma protein panel that detects ALS disease process years before clinical onset.
New review reveals how senescent brain cells fuel Alzheimer's progression and highlights promising senolytic therapies for cognitive protection.
Comprehensive review maps molecular pathways driving vascular dementia, highlighting novel therapeutic approaches.
Study of 2,366 women shows biological aging markers predict future increases in tau, amyloid, and neuroinflammation proteins linked to dementia.
Scientists uncover the molecular mechanisms driving microglial aging in the brain, offering insights into neurodegeneration.